EUVIMEDEUVIMED entdecken
Crossref

Use of Dolutegravir for Treatment of HTLV-1

Carlos Brites iD, Iris Montaño-Castellon, Cleyde Marconi, María Arriaga-Gutiérrez, Rafaela Mayoral, Estela Luz, Eduardo M Netto

Clinical Infectious Diseases · 21.05.2026

DOI: 10.1093/cid/ciag324 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 21.05.2026. Verfasst von Carlos Brites und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Medicine, Federal University of Bahia. Die Arbeit nennt 3 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Medicine, School of Medicine, Federal University of Bahia.
  • Fundação Bahiana de Infectologia.

ORCID-Profile: Carlos Brites

Zitieren

APA

Brites, C., Montaño-Castellon, I., Marconi, C., Arriaga-Gutiérrez, M., Mayoral, R., Luz, E., & Netto, E. M. (2026). Use of Dolutegravir for Treatment of HTLV-1. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag324

Vancouver

Brites C, Montaño-Castellon I, Marconi C, Arriaga-Gutiérrez M, Mayoral R, Luz E, et al. Use of Dolutegravir for Treatment of HTLV-1. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag324

BibTeX
@article{Brites2026,
  author = {Brites, Carlos and Montaño-Castellon, Iris and Marconi, Cleyde and Arriaga-Gutiérrez, María and Mayoral, Rafaela and Luz, Estela and Netto, Eduardo M},
  title = {Use of Dolutegravir for Treatment of HTLV-1},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag324}
}
Kostenlos starten →